Growing evidence that exercise is safe and beneficial for cancer patients and cancer survivors.

News source: 
Anticancer Fund

There is growing evidence that exercise is safe and beneficial for cancer patients and cancer survivors.
Recent findings on breast cancer confirm that exercise may decrease fatigue and increase energy during breast cancer treatment.

A large meta-analysis that examined the effects of exercise on women who were receiving chemotherapy and/or radiation, showed that women who exercised experienced improvements in cardiovascular functioning, muscular strength and quality of life compared to patients who didn’t exercise. Interventions included aerobic exercise, resistance exercise or both. The results of this review suggest that exercise is a safe, feasible, and efficacious intervention in breast cancer patients who are undergoing different kind of treatments. Additional research addressing the different modes of exercise during each type of treatment is warranted to assess the comparable efficacy of the various exercise modes during established breast cancer treatments and to help guide the oncologists and health/fitness professionals in implementing exercise as a supportive care intervention for breast cancer patients.

Another new but small study, provide evidence that women with risk or at risk for breast cancer-related lymphedema can safely perform moderate-intensity upper body resistance exercises without fear of developing or worsening lymphedema.

Another new article shows that lung cancer patients improved their sleeping quality and quality of life when they participated in a walking program. The intervention consisted of walking at a moderate intensity for 40 minutes three times a week. The authors concluded that the walking programm is an effective intervention for improving the subjective and objective sleep quality of lung cancer patients and can be considered an optional component of lung cancer rehabilitation.

 

Sources: (abstract only)

- https://www.ncbi.nlm.nih.gov/pubmed/27258052

- https://www.ncbi.nlm.nih.gov/pubmed/27516182